This diversity of tumor cells’ profiles led to distinguishing different classification levels, i.e., based on histology and expression profiles of the molecular markers; estrogen receptor (ER), progesterone receptor (PR) and the overexpression or gene amplification of human epidermal growth factor receptor 2 (HER2). This evidence concerns the gene ERBB2 and neoplasm.